Late Breaking Abstract Submissions

Beginning December 5, 2013, SGO will accept abstract submissions for consideration as a Late-Breaking Abstract at the SGO 2014 Annual Meeting on Women's Cancer®. This session will highlight data of the highest scientific impact that has become available since the original 2014 Annual Meeting abstract submission deadline. An example of a Late-Breaking Abstract would be the results of a recently closed Phase III trial for which no preliminary data are available at the time of the abstract submission deadline. Abstract submissions for this session can also include preliminary findings and conclusions if data analysis is still ongoing. However, trials or experiments for which data collection is not yet complete are discouraged. Submitted abstracts should reflect scientific methods and statistical power suitable for a plenary presentation and should not be previously published or presented.

Late-Breaking Abstracts must clearly identify the objectives, methods, results and conclusions of the study. Abstracts already submitted in response to the original Call for Abstracts for the 2014 Annual Meeting are not eligible for resubmission.

Thank you for your interest in submitting your research for the Late Breaking Abstract Session at the Society of Gynecologic Oncology (SGO) 45th Annual Meeting on Women's Cancer.

Please see complete guidelines below.

SGO will accept submissions for Late Breaking scientific abstracts Thursday, December 5, 2014 through Monday, February 10, 2014, at 11:59 p.m. Central Time.
To start a new Late Breaking Abstract submission, select the appropriate submission type below. If you have started an abstract submission and have an ID and password, please enter it in the box on the right.


Late Breaking Abstract Submissions

Submission Deadline: Monday, February 10, 2014, at 11:59pm Central time.

Each Abstract Submission must clearly identify the following:

    Objectives: an introductory sentence indicating the purpose of the study

    Methods: a brief description of pertinent experimental procedures, including statistical evaluation where appropriate

    Results: a summary of the NEW, UNPUBLISHED DATA

    Conclusions: a statement of the conclusions

Please note: The character count limit of 2,000 does not include your Abstract Title, Author String, or spaces.


  1. Late Breaking Abstract Guidelines

    Abstracts are selected on the basis of scientific merit and are allocated to the Late Breaking Session through a blinded peer review process. The Program Committee reserves the right to select the most appropriate forum for presentation.

    SGO encourages all medical professionals who are part of the women's cancer care team to submit original research for peer review by the 2014 Annual Meeting Program Committee.

    In addition to all topics pertaining to women's cancer, authors are encouraged to submit abstracts focusing on five key concept areas, as outlined below.

    • Cancer Care Delivery System and Payment Reform: Research on quality measures and outcomes, cost-effectiveness, and models for cancer care delivery and payment in the era of the Affordable Care Act.
    • Global Efforts to End Women's Cancers: Efforts to prevent, control, and eradicate women's cancers, including HPV and cervical cancer, around the world.
    • Clinical Trials in Gynecologic Cancers: Phase I, II, III and Trials in Progress: From personalized medicine to practice-changing studies in ovarian, cervical and endometrial cancer.
    • Cancer in Vulnerable Populations: Obesity, Elderly and the Underserved: Research on risks, prevention, treatment and outcomes for women in vulnerable populations with gynecologic cancers.
    • Survivorship and Supportive Care: Studies focused on how we can support our patients through and beyond their treatment for gynecologic cancers.

    In addition to the key concepts, authors are encouraged to submit research in any of the following categories:

    1. Breast Cancer
    2. Cervical Cancer
    3. Chemotherapy
    4. Clinical Practice Issues
    5. Clinical Trials - Phase I
    6. Clinical Trials - Ovary/Fallopian Tube/Primary Peritoneal Cancer/Breast, Phase II/III
    7. Clinical Trials - Cervix Phase II/III
    8. Clinical Trials - Uterine Cancer/Endometrial/Sarcoma, Phase II/III
    9. Uterine/Endometrial Cancer
    10. Public Health/Epidemiology
    11. Hereditary Cancers & The Role of Genetics
    12. Ovarian/Fallopian Tube/Primary Peritoneal Cancer
    13. Surgical Techniques/Minimally Invasive Surgery/Surgical Technology including Robotics
    14. Supportive Care
    15. Quality of Life
    16. Gestational Trophoblastic Disease/Vulvar & Vaginal Cancers/Rare Tumors/Sarcomas
    17. Surgical Films
    18. Translational Research/Basic Science
    Objectives, Methods, Results, and Conclusions must be clearly identified within the submission.

    Individuals with abstracts selected for presentation will be asked to postpone publication of their manuscript in any journal until the conclusion of the Annual Meeting. Abstracts selected for Late Breaking presentations will be published in Gynecologic Oncology. For those authors wishing to submit manuscripts for publication in Gynecologic Oncology, its editors will make every effort to ensure that accepted papers are promptly published after the Annual Meeting.

    Unauthorized recordings of sessions by means of audio tapes, video, or still photography requiring flash devices, special lighting, or bulky equipment are prohibited. The SGO reserves the right to all video and/or audio recordings of presentations at The Annual Meeting on Women's Cancer®.

    Expenses associated with the submission and presentation of an abstract are the responsibility of the presenter, and are not reimbursed or covered by the Society of Gynecologic Oncology.

    There is a 2,000 character count limit for all submissions. This does not include your Title or Author String, allotted table or graph, or spaces.

  2. Technical Support

    For help in submitting an abstract online: Contact technical support.